FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894919341> ?p ?o ?g. }

• W2894919341 endingPage "1433" @default.
• W2894919341 startingPage "1425" @default.
• W2894919341 abstract "There have been no established parameters to predict responsiveness to i.v. cyclophosphamide (IVCY) pulse therapy in combination with corticosteroids in patients with interstitial lung disease (ILD) related to systemic sclerosis (SSc). This retrospective study was conducted to determine predictive factors for efficacy of IVCY at the time of before and during the treatment. Thirty-two Japanese SSc patients, ever treated for ILD with IVCY in combination with prednisolone, were analyzed retrospectively. We performed detailed time-course analyses of parameters derived from blood samples and pulmonary function tests. With the exclusion of eight unclassified patients, 24 patients were classified into 14 good responders (GR) or 10 poor responders (PR) on the basis of changes in percent predicted diffusing capacity for carbon monoxide (DLco). Pretreatment percent predicted DLco was significantly reduced in PR compared with GR. In addition, serum parameters such as Krebs von den Lungen-6 (KL-6), surfactant protein D (SP-D) and C-reactive protein were significantly higher in PR than in GR. Furthermore, our time-course analyses revealed a transient increase in serum KL-6 levels with a peak at 3 months after the first infusion of cyclophosphamide, which showed no relation to therapeutic efficacy. Moreover, continuously high serum KL-6 levels (>2000 U/mL) and rapid decrease in SP-D levels (<200 ng/mL) during IVCY were remarkably characteristic of PR and GR, respectively. ILD severity/activity before treatment and variability of serum KL-6 and SP-D levels during treatment may be useful to predict therapeutic effects of IVCY on SSc-ILD." @default.
• W2894919341 created "2018-10-12" @default.
• W2894919341 creator A5007508591 @default.
• W2894919341 creator A5009161482 @default.
• W2894919341 creator A5010201656 @default.
• W2894919341 creator A5014172311 @default.
• W2894919341 creator A5019299627 @default.
• W2894919341 creator A5022064467 @default.
• W2894919341 creator A5024903237 @default.
• W2894919341 creator A5031341977 @default.
• W2894919341 creator A5032244860 @default.
• W2894919341 creator A5035808141 @default.
• W2894919341 creator A5040904640 @default.
• W2894919341 creator A5045059471 @default.
• W2894919341 creator A5051512176 @default.
• W2894919341 creator A5057860815 @default.
• W2894919341 creator A5065468368 @default.
• W2894919341 creator A5069895972 @default.
• W2894919341 date "2018-10-05" @default.
• W2894919341 modified "2023-09-30" @default.
• W2894919341 title "Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study" @default.
• W2894919341 cites W1504572945 @default.
• W2894919341 cites W1524342218 @default.
• W2894919341 cites W1855316965 @default.
• W2894919341 cites W1965264094 @default.
• W2894919341 cites W1967641907 @default.
• W2894919341 cites W1993106245 @default.
• W2894919341 cites W2005041300 @default.
• W2894919341 cites W2011699603 @default.
• W2894919341 cites W2024874837 @default.
• W2894919341 cites W2039204046 @default.
• W2894919341 cites W2049234024 @default.
• W2894919341 cites W2049511380 @default.
• W2894919341 cites W2056364917 @default.
• W2894919341 cites W2081649216 @default.
• W2894919341 cites W2092116344 @default.
• W2894919341 cites W2095975942 @default.
• W2894919341 cites W2110699847 @default.
• W2894919341 cites W2131014787 @default.
• W2894919341 cites W2139777957 @default.
• W2894919341 cites W2159860060 @default.
• W2894919341 cites W2164096595 @default.
• W2894919341 cites W2164805010 @default.
• W2894919341 cites W2168198817 @default.
• W2894919341 cites W2325870812 @default.
• W2894919341 cites W2498506084 @default.
• W2894919341 cites W4230768669 @default.
• W2894919341 cites W4237651240 @default.
• W2894919341 cites W4248278769 @default.
• W2894919341 cites W4249200669 @default.
• W2894919341 doi "https://doi.org/10.1111/1346-8138.14669" @default.
• W2894919341 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30289572" @default.
• W2894919341 hasPublicationYear "2018" @default.
• W2894919341 type Work @default.
• W2894919341 sameAs 2894919341 @default.
• W2894919341 citedByCount "18" @default.
• W2894919341 countsByYear W28949193412019 @default.
• W2894919341 countsByYear W28949193412020 @default.
• W2894919341 countsByYear W28949193412021 @default.
• W2894919341 countsByYear W28949193412022 @default.
• W2894919341 countsByYear W28949193412023 @default.
• W2894919341 crossrefType "journal-article" @default.
• W2894919341 hasAuthorship W2894919341A5007508591 @default.
• W2894919341 hasAuthorship W2894919341A5009161482 @default.
• W2894919341 hasAuthorship W2894919341A5010201656 @default.
• W2894919341 hasAuthorship W2894919341A5014172311 @default.
• W2894919341 hasAuthorship W2894919341A5019299627 @default.
• W2894919341 hasAuthorship W2894919341A5022064467 @default.
• W2894919341 hasAuthorship W2894919341A5024903237 @default.
• W2894919341 hasAuthorship W2894919341A5031341977 @default.
• W2894919341 hasAuthorship W2894919341A5032244860 @default.
• W2894919341 hasAuthorship W2894919341A5035808141 @default.
• W2894919341 hasAuthorship W2894919341A5040904640 @default.
• W2894919341 hasAuthorship W2894919341A5045059471 @default.
• W2894919341 hasAuthorship W2894919341A5051512176 @default.
• W2894919341 hasAuthorship W2894919341A5057860815 @default.
• W2894919341 hasAuthorship W2894919341A5065468368 @default.
• W2894919341 hasAuthorship W2894919341A5069895972 @default.
• W2894919341 hasConcept C126322002 @default.
• W2894919341 hasConcept C16020263 @default.
• W2894919341 hasConcept C165637977 @default.
• W2894919341 hasConcept C2776694085 @default.
• W2894919341 hasConcept C2776755627 @default.
• W2894919341 hasConcept C2777543607 @default.
• W2894919341 hasConcept C2777714996 @default.
• W2894919341 hasConcept C3018587741 @default.
• W2894919341 hasConcept C71924100 @default.
• W2894919341 hasConcept C75603125 @default.
• W2894919341 hasConcept C90924648 @default.
• W2894919341 hasConceptScore W2894919341C126322002 @default.
• W2894919341 hasConceptScore W2894919341C16020263 @default.
• W2894919341 hasConceptScore W2894919341C165637977 @default.
• W2894919341 hasConceptScore W2894919341C2776694085 @default.
• W2894919341 hasConceptScore W2894919341C2776755627 @default.
• W2894919341 hasConceptScore W2894919341C2777543607 @default.
• W2894919341 hasConceptScore W2894919341C2777714996 @default.
• W2894919341 hasConceptScore W2894919341C3018587741 @default.
• W2894919341 hasConceptScore W2894919341C71924100 @default.

• next